Insight Brief
Valuing the Patient Voice in Medicines Access Decisions - How Does Australia Compare?
Mar 25, 2026
Download
How does Australia compare internationally on incorporating the patient voice into health technology assessment (HTA)? This brief benchmarks Australia against Canada, France, Germany and the UK over the last decade, and clarifies the difference between consumer input (lived experience) and consumer evidence (including patient‑reported outcomes and real‑world evidence). It highlights where Australia is ahead, where it lags, and practical opportunities to strengthen patient‑informed evidence in medicines access decision‑making.

Related solutions

Contact Us